Culture

URBANA –University of Illinois scientists from a variety of disciplines have teamed up to examine the factors that contribute to childhood obesity. Why? Because individual researchers have found that the problem is too complicated for any of them to tackle alone.

Use of established fracture prediction methods in older patients with type 2 diabetes mellitus (DM) found that scores from these methods were associated with hip and nonspine fracture risk, and a certain score associated with higher risk of fracture compared to persons without DM, according to a study in the June 1 issue of JAMA. Because patients with type 2 DM often have higher levels of bone mineral density (BMD), it has been uncertain the applicability of fracture risk screening methods typically used for patients with lower levels of BMD.

AUGUSTA, Ga. – A facelift incision and robotics can help surgeons safely remove a portion of a diseased thyroid from some patients without the characteristic neck scar.

Georgia Health Sciences University surgeons developed the technique utilizing the remote access capabilities of robots, experience gained from another no-neck-scar approach through the armpit and earlier success removing the largest salivary gland from the lower jaw region.

A Queen's University professor is helping standardize practices for healthcare ethicists who consult and give guidance on medical ethics issues to doctors, nurses and patients across the country.

WINSTON-SALEM, N.C. – May 31, 2011 – The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center.

The study appears online in the Clinical Journal of the American Society of Nephrology and is scheduled for the July print issue.

A prior fracture at least doubles a patient's future fracture risk – yet numerous studies from across the world have found that healthcare systems fail to respond to the first fracture to prevent future fractures. Professor Cyrus Cooper, chair of the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) and director of the MRC Lifecourse Epidemiology Unit, University of Southampton in the UK stated, "Studies from the UK, USA and Australia have reported that 45% or more of today's hip fracture patients have a prior fracture history.

Toronto – Not allowed to advertise your booze or smokes on a billboard?

That's okay. Research shows online advertising works especially well in places with government ad bans.

"If you want to regulate the offline world, you have to remember that people have access online too and you have to think about how that online world is going to mitigate the effects of your regulation," says Avi Goldfarb, a marketing professor at the University of Toronto's Rotman School of Management who co-wrote a study on the topic with Catherine Tucker of MIT's Sloan School of Management.

Venous thromboembolism (VTE) is the third most common type of cardiovascular disease after coronary heart disease and stroke. Researchers at the Centre for Primary Health Care Research in Malmö have mapped the significance of hereditary factors for venous thromboembolism in the entire Swedish population by studying the risk of VTE in children of parents with VTE compared with the children of parents who have not had VTE.

May 30, 2011 – Fredericton, N.B. – In recent years, the apparent decline in boys' academic success rates has troubled politicians, researchers, and educators. It has been described as an educational crisis and a failure of the traditional school setting. The decline has spurred scores of potential solutions to the problem, including the adoption of same-sex classrooms as a way to better address boys' educational needs.

Two years ago, a widely publicized scientific report plucked an old mouse virus out of obscurity and held it up as a possible cause of Chronic Fatigue Syndrome. According to a new study published today by a group of researchers in California, Wisconsin and Illinois, that report was wrong.

The mouse virus is not the culprit in Chronic Fatigue Syndrome, said University of California, San Francisco Professor Jay A. Levy, MD, the senior author on the study, published this week by the journal Science.

Debate about the public health response to Haiti's cholera epidemic continues as the crisis enters its ninth month, with some experts arguing that a vaccination campaign in Haiti would be neither feasible nor cost-effective, and advocating putting forth other measures.

PROVIDENCE, R.I. [Brown University] — The end of the Norse settlements on Greenland likely will remain shrouded in mystery. While there is scant written evidence of the colony's demise in the 14th and early 15th centuries, archaeological remains can fill some of the blanks, but not all.

A new position paper by researchers at the European Centre for the Environment and Human Health (ECEHH - part of the Peninsula College of Medicine and Dentistry) and the University of Birmingham has compared the benefits of interaction with actual and virtual natural environments and concluded that the development of accurate simulations are likely to be beneficial to those who cannot interact with nature because of infirmity or other limitations: but virtual worlds are not a substitute for the real thing.

Attending frequently with medically unexplained symptoms is distressing for both patient and doctor and effective treatment or management options are limited: one in five patients have symptoms that remain unexplained by conventional medicine. Studies have shown that the cost to the NHS of managing the treatment of a patient with medically unexplained symptoms can be twice that of a patient with a diagnosis.

The results of this study, conducted in Germany, re-open the debate on whether it is ethical to conduct placebo-controlled studies where patients in the placebo-group are at a serious disadvantage compared to patients taking the new treatments. The study analysed current study designs, for new therapies such as abatacept (Orencia®), golimumab (Simponi®) or tocilizumab (Actemra®), and showed that patients in the placebo group experienced no change in medication, having to continue with their former, ineffective treatment plus placebo.